Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is BATM Advanced Communications OCF Margin %?
BATM Advanced CommunicationsCHIX:BVCL 33 OCF Margin % is 2.29% as of Jun. 2026, which is 43% above its 10-year median of 1.60. GuruFocus rates CHIX:BVCL with a GF Score™ of 33/100 and a GF Value™ of £0.15 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 813 Medical Devices & Instruments companies, BATM Advanced Communications ranks worse than 64.7% on this metric.
The historical rank and industry rank for BATM Advanced Communications's OCF Margin % or its related term are showing as below:
CHIX:BVCl'
s OCF Margin % Range Over the Past 10 Years
Min: -5.65 Med: 1.6 Max: 10.06
Current: -2.57
During the past 13 years, the highest OCF Margin % of BATM Advanced Communications was 10.06%. The lowest was -5.65%. And the median was 1.60%.
CHIX:BVCl's OCF Margin % is ranked worse than 64.7% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.43
vs CHIX:BVCl: -2.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BVCL vs ISRG, BDX, RMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, BATM Advanced Communications's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BATM Advanced Communications OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BATM Advanced Communications's OCF Margin % distribution charts can be found below:
* The bar in red indicates where BATM Advanced Communications's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BATM Advanced Communications (CHIX:BVCL) has a OCF Margin % of 2.29% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BATM Advanced Communications and its competitors. This is 43% above median its historical median of 1.60. According to the industry distribution chart, BATM Advanced Communications ranks #526 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 64.7%.
Is BATM Advanced Communications' OCF Margin % too high?
BATM Advanced Communications' current OCF Margin % of 2.29% is 43% above median its 10-year median of 1.60. The Medical Devices & Instruments industry median OCF Margin % is 6.43. BATM Advanced Communications' value of 2.29% is 64.4% below this industry median. Based on the distribution chart, BATM Advanced Communications ranks #526 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BATM Advanced Communications has a GF Score™ of 33/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BATM Advanced Communications' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, BATM Advanced Communications ranks #526 out of 813 companies for OCF Margin %. This places BATM Advanced Communications in the lower half of its industry. The industry median OCF Margin % is 6.43. BATM Advanced Communications' value of 2.29% is 64.4% below this benchmark. While the company's 10-year median is 1.60 vs. the industry median of 6.43, BATM Advanced Communications has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.43, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BATM Advanced Communications's current OCF Margin % of 2.29% is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BATM Advanced Communications and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BATM Advanced Communications's current OCF Margin % is 2.29%, which is 43% above median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BATM Advanced Communications stock overvalued right now?
Based on GuruFocus' analysis, BATM Advanced Communications (CHIX:BVCL) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.15, compared to a current price of £0.12 — trading 20% below its estimated fair value. The current OCF Margin % is 2.29%, which is 43% above median its 10-year median of 1.60 and 64.4% below the Medical Devices & Instruments industry median of 6.43. BATM Advanced Communications' overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BATM Advanced Communications (CHIX:BVCL), the current OCF Margin % is 2.29% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BATM Advanced Communications (CHIX:BVCL) Overvalued in 2026?
Based on GuruFocus' analysis, BATM Advanced Communications stock appears to be undervalued.
The current stock price of £0.12 is trading 20% below its estimated GF Value™ of £0.15.
GuruFocus considers BATM Advanced Communications to be Modestly Undervalued.
Key valuation signals for CHIX:BVCL:
OCF Margin %: 2.29% (43% above median its 10-year median of 1.60)
GF Value™: £0.15 vs. price of £0.12 (20% below fair value)
Industry Position: 64.4% below the Medical Devices & Instruments median (#526 of 813)
No single metric tells the full story. See the CHIX:BVCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BATM Advanced Communications Ltd is an Israel-based technology company. It is engaged in the development, production and supply of real-time technologies and associated services in three core application areas: Networks, Cyber and Diagnostics. In addition, the Group's non-core activities comprised the production and supply of pharmaceutical applications and the distribution of third-party pharmaceutical and environmental monitoring products. The company organizes its business operations into three divisions: Networking, Cyber Division, and Diagnostics Division. It generates majority of revenue from Diagnostics mainly engaged in sales and distribution of in vitro diagnostics reagents and instruments. It operates in three geographical areas: the United States of America, Israel and Europe.
33GF Score
Get the complete analysis for CHIX:BVCL
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BVCL has been successfully added to your 
